Dr. Aakriti Garg Shukla, MD

Dr. Shukla practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Shukla's NPI, 1578976973, was assigned on June 4, 2014. Dr. Shukla graduated from Vagelos College of Physicians and Surgeons in 2014. Dr. Shukla's New York license number on file is 314658.

Dr. Shukla's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Shukla's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Shukla is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shukla practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Shukla's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Shukla is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Shukla's licenses on file in 5 states: New York, Delaware, Pennsylvania, New Jersey and Maryland.

Dmand AI lists cataract, cataract surgery with lens implant, dry eye, eyelid inflammation, glaucoma, glaucoma surgery, retinal detachment and retinal occlusion among the conditions Dr. Shukla treats.

CMS data shows 3,269 Medicare services from Dr. Shukla across 15 procedure codes in 2024, for 606 Medicare patients. Medicare paid $225,862 for them.

CMS counts 606 Medicare patients who saw Dr. Shukla in 2024. The largest group is 75 to 84, with 271 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shukla's median patient age at 69, with 58% women.

In 2024, Dr. Shukla wrote 2,322 Medicare Part D claims for 500 patients. 55% of them were for generic drugs. CMS names the drug for 2,234 of them, across 26 drugs with 11 or more claims each, at $339,436 in total drug cost. In 2023, CMS named 1,842 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Shukla for performance year 2024, reported through an alternative payment model (APM). Dr. Shukla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 119 procedures of cataract surgery by Dr. Shukla, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 65 papers to Dr. Shukla, published from 2014 to 2025. 2022 was the busiest year, with 9. The most frequent topics are Glaucoma, Intraocular Pressure and Glaucoma Drainage Implants. Dr. Shukla has published most often in Ophthalmol Glaucoma. Dr. Shukla's most frequent co-authors are Natasha Nayak Kolomeyer, MD, Marlene R. Moster, MD and George A. Cioffi, MD.

Dmand AI links Dr. Shukla to 1 clinical trial. Conditions studied include Glaucoma, Open-Angle and Glaucoma.

CMS Open Payments shows 103 general payments to Dr. Shukla from 14 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 73% of the total. Alcon Laboratories Inc paid the most, $41,556.

Dr. Shukla graduated from Vagelos College of Physicians and Surgeons in 2014.

Dr. Shukla is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.